Abstract:Background: Inclusion bodies (IBs) are protein aggregates in recombinant bacterial cells containing mainly the target recombinant protein. Although it has been shown that IBs contain functional proteins along with protein aggregates, their direct application as pharmaceuticals is hindered by their heterogeneity and hazardous contaminants with bacterial origin. Therefore, together with the production of soluble species, IBs remain the main source for manufacture of recombinant proteins with medical application. The quality and composition of the IBs affect the refolding yield and further purification of the recombinant protein. The knowledge whether nucleic acids are genuine components or concomitant impurities of the IBs is a prerequisite for the understanding of the IBs formation and for development of optimized protocols for recombinant protein refolding and purification. IBs isolated from Escherichia coli overexpressing human interferon-gamma (hIFNγ), a protein with therapeutic application, were used as a model. Results: IBs were isolated from E. coli LE392 cells transformed with a hIFNγ expressing plasmid under standard conditions and further purified by centrifugation on a sucrose cushion, followed by several steps of sonication and washings with non-denaturing concentrations of urea. The efficiency of the purification was estimated by SDS-PAGE gel electrophoresis and parallel microbiological testing for the presence of residual intact bacteria. Phenol/chloroform extraction showed that the highly purified IBs contain both DNA and RNA. The latter were studied by UV spectroscopy and agarose gel electrophoresis combined with enzymatic treatment and hybridization. DNA was observed as a diffuse fraction mainly in the range of 250 to 1000 bp. RNA isolated by TRIzol® also demonstrated a substantial molecular heterogeneity. Hybridization with 32P-labelled oligonucleotides showed that the IBs contain rRNA and are enriched of hIFNγ mRNA. Conclusions: The results presented in this study indicate that the nucleic acids might be intrinsic components rather than co-precipitated impurities in the IBs. We assume that the nucleic acids are active participants in the aggregation of recombinant proteins and formation of the IBs that originate from the transcription and translation machinery of the microbial cell factory. Further studies are needed to ascertain this notion.

The quality of inclusion body protein

Modeling of Protein Refolding from Inclusion Bodies.

Non-denaturing solubilization of inclusion bodies

Custom made inclusion bodies: impact of classical process parameters and physiological parameters on inclusion body quality attributes

Progress in Study on Refolding and Renaturation of Inclusion Bodies

State-of-the-art and novel approaches to mild solubilization of inclusion bodies

Nucleic acids in inclusion bodies obtained from E. coli cells expressing human interferon-gamma

A Single Freeze-Thawing Cycle for Highly Efficient Solubilization of Inclusion Body Proteins and Its Refolding into Bioactive Form

Refolding and Structural Characteristic of TRAIL/Apo2L Inclusion Bodies from Different Specific Growth Rates of Recombinant Escherichia Coli.

Time to consider ruling out inclusion bodies denaturing protocols for spontaneous solubilization of biologically active proteins

Highly Efficient Production of Soluble Proteins from Insoluble Inclusion Bodies by a Two-Step-denaturing and Refolding Method.

Human growth hormone inclusion bodies present native-like secondary and tertiary structures which can be preserved by mild solubilization for refolding

Formation of Active Inclusion Bodies Induced by Hydrophobic Self-Assembling Peptide GFIL8

Purification and Refolding Escherichia Coli Produced Enterokinase Inclusion Bodies Immobilized by Nickel Chelating Chromatography

Online monitoring of protein refolding in inclusion body processing using intrinsic fluorescence

Complex Inclusion Bodies and Defective Proteome Hubs in Neurodegenerative Disease: New Clues, New Challenges

Effect of Induction Time on Quality and Renaturation of Inclusion Bodies with Procarboxypeptidase B

GroEL/ES Mediated the in Vivo Recovery of TRAIL Inclusion Bodies in Escherichia Coli.

Refolding Strategies from Inclusion Bodies in a Structural Genomics Project

[In vitro renaturation of proteins from inclusion bodies]

Formation of inclusion bodies may be the key factor for the stability of expressed products in E. coli.